Guedon-Moreau L - Search Results

1

Fontaine G, Guedon-Moreau L, Frank R, Lascault G, Fontaliran F, Tonet J, Himbert C, Grosgogeat Y. Fontaine G, et al. Ann Cardiol Angeiol (Paris). 1992 Sep;41(7):399-410. Ann Cardiol Angeiol (Paris). 1992. PMID: 1285629 Review. French.

2

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.

Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators. Marijon E, et al. Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330420 Free PMC article.

3

[Determinants of malignant vasovagal syncopes with asystole disclosed by the tilting test and therapeutic implications].

Kouakam C, Lacroix D, Klug D, Ben Ameur Y, Guédon-Moreau L, Kacet S, Lekieffre J. Kouakam C, et al. Ann Cardiol Angeiol (Paris). 1997 Mar;46(3):135-43. Ann Cardiol Angeiol (Paris). 1997. PMID: 9183393 French.

4

[Converting enzyme inhibitors in the treatment of arterial hypertension].

Guedon J, Guedon-Moreau L. Guedon J, et al. Ann Cardiol Angeiol (Paris). 1988 Dec;37(10):559-62. Ann Cardiol Angeiol (Paris). 1988. PMID: 3223720 French.

5

[Quality of life in atrial fibrillation patients. Clinical stakes].

Guédon-Moreau L. Guédon-Moreau L. Ann Cardiol Angeiol (Paris). 2009 Dec;58 Suppl 1:S19-21. doi: 10.1016/S0003-3928(09)73393-1. Ann Cardiol Angeiol (Paris). 2009. PMID: 20103173 French.

6

[Atrial fibrillation: challenge of antithrombotic treatment].

Guédon-Moreau L, Kacet S. Guédon-Moreau L, et al. Ann Cardiol Angeiol (Paris). 2009 Dec;58 Suppl 1:S25-30. doi: 10.1016/S0003-3928(09)73395-5. Ann Cardiol Angeiol (Paris). 2009. PMID: 20103175 French.

7

[Is programmed ventricular stimulation still up to date in the medicinal evaluation of ventricular tachycardia?].

Kouakam C, Guédon-Moreau L, Kacet S. Kouakam C, et al. Therapie. 1998 Nov-Dec;53(6):533-41. Therapie. 1998. PMID: 10070230 Review. French.

8

Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory.

Guédon-Moreau L, Chevalier P, Marquié C, Kouakam C, Klug D, Lacroix D, Brigadeau F, Kacet S; ECOST trial Investigators. Guédon-Moreau L, et al. Eur Heart J. 2010 Sep;31(18):2246-52. doi: 10.1093/eurheartj/ehq203. Epub 2010 Jun 30. Eur Heart J. 2010. PMID: 20591841 Free PMC article. Clinical Trial.

9

Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study.

Klein C, Kouakam C, Lazarus A, de Groote P, Bauters C, Marijon E, Mouquet F, Degand B, Guyomar Y, Mansourati J, Leclercq C, Guédon-Moreau L; ECOST-CRT study Investigators. Klein C, et al. Among authors: guedon moreau l. Europace. 2024 Oct 3;26(10):euae233. doi: 10.1093/europace/euae233. Europace. 2024. PMID: 39400005 Free PMC article. Clinical Trial.

10

[Pro-arrhythmic effects of anti-arrhythmic agents. Study methods and difficulties in analysis].

Libersa C, Caron J, Guedon-Moreau L, Lacroix D. Libersa C, et al. Therapie. 1992 Sep-Oct;47(5):363-5. Therapie. 1992. PMID: 1299972 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters